HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Feasibility Study Agreement
UK's Hemogenyx Pharmaceuticals H1 loss widens on share-based payments
Half-year Financial Report
Exercise of Warrants and Issue of Equity
Brief: Hemogenyx Pharmaceuticals Signs Collaboration Agreement With Cellin Technologies
Collaboration with Cellin Technologies
Brief: Hemogenyx Pharmaceuticals Signs LOI To Establish Scientific & Clinical Collaboration
Collaboration and Company Update
Notice of AGM
Grant of Options and Extension of Warrant Term
Final Results
Brief: Hemogenyx Pharmaceuticals Raises £3 Million To Accelerate Clinical Development
Institutional Fundraise
Tech Transfer Completion and Clinical Trial Update
Holding(s) in Company
Exercise of Warrants and Issue of Equity
Issue of Equity - Correction
Issue of Equity
Holding(s) in Company